Cargando…
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
BACKGROUND: Palmoplantar pustulosis is a rare but painful and debilitating disease. It consistently ranks the highest of all psoriasis phenotypic variants in terms of symptoms and functional impairment. Management of plaque-type psoriasis has been revolutionised in the last 10 years with the advent...
Autores principales: | Cornelius, Victoria, Wilson, Rosemary, Cro, Suzie, Barker, Jonathan, Burden, David, Griffiths, Christopher E. M., Lachmann, Helen, McAteer, Helen, Reynolds, Nick, Pink, Andrew, Warren, Richard B., Capon, Francesca, Smith, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116430/ https://www.ncbi.nlm.nih.gov/pubmed/30157880 http://dx.doi.org/10.1186/s13063-018-2841-y |
Ejemplares similares
-
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial
por: Cro, Suzie, et al.
Publicado: (2020) -
Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial
por: Cro, Suzie, et al.
Publicado: (2018) -
Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)
por: Cro, S., et al.
Publicado: (2021) -
Clinical and genetic differences between pustular psoriasis subtypes
por: Twelves, Sophie, et al.
Publicado: (2019) -
Clinical Disease Measures in Generalized Pustular Psoriasis
por: Burden, A. David, et al.
Publicado: (2022)